Skip to main content
Research_

Are you overweight and have Type 2 Diabetes?

We are investigating a new injectable medication for diabetes management and weight loss.

This study will run for a maximum of 23 weeks, with visits required on a regular basis to The Charles Perkins Centre in Camperdown. 

You will be medically supervised and there will be no costs involved. You will also be reimbursed for out of pocket expenses including travel

This study is being sponsored by Boehringer Ingelheim Pharmaceuticals, Inc and conducted at Boden Collaboration, The University of Sydney at the Charles Perkins Centre.

Eligibility

You may be eligible to participate in this study if you:

  • Are aged 18-75
  • Have Type 2 Diabetes
  • Are taking only metformin to manage your diabetes.
  • Are overweight

How to participate

If you are interested in assisting with this important and exciting area of research, please contact the study facilitator: 8627 0101 or clinicaltrials.boden@sydney.edu.au

Please do leave a message with your name and contact details so we can return your call.